MedTrace Logo

Study to Assess the Stability, Efficacy and Safety of the Silent™ Hip Prosthesis in Primary Total Hip Replacement

NCT00894140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2016-09-26

No results posted yet for this study

Summary

The purpose of this study is to determine if the Silent™ hip, when used as part of an artificial hip joint, is stable and effective in treatment of patients with joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical, standard and special x-rays (RSA) to allow the position of the Silent Hip within the bone to be accurately monitored.

Conditions

Interventions

DEVICE

DePuy Silent™ Hip femoral prosthesis

A short cementless, femoral component for use in total hip arthroplasty

Sponsors & Collaborators

  • Johnson and Johnson Medical

    collaborator UNKNOWN

  • DePuy International

    lead INDUSTRY

Principal Investigators

  • Tammy ODell, BS · DePuy International

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2004-11-30
Completion
2014-05-31

Countries

  • Australia
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00894140 on ClinicalTrials.gov